Menthol and filter ventilation in cigarettes: prevalence estimates and relationships with harm perception and smoking exposure

Author:

Carroll Dana MowlsORCID,Bittencourt Lorna,Tessier Katelyn M,Usman Ayaantuu,Stepanov IrinaORCID,Hatsukami Dorothy KORCID

Abstract

IntroductionMenthol and filter ventilation (FV) contribute to cigarette appeal. This observational study examines the US prevalence of menthol versus non-menthol cigarette use by FV and how harm perceptions, cigarettes per day and biomarkers of exposure vary.MethodsPopulation Assessment of Tobacco and Health Study (2013–2014) was merged with FV levels of cigarettes and restricted to daily smoking adults who had a usual cigarette variety and did not regularly use other tobacco (N=1614). Weighted descriptive statistics identified the prevalence of menthol and non-menthol use by low (0.02%–10.04%), moderate (10.05%–23.40%), high (23.41%–28.12%) and very high FV (28.13%–61.10%). Weighted linear regression was used to examine differences in outcomes by menthol/FV adjusted for potential confounders.ResultsThe prevalence of a usual brand that was non-menthol, low FV was the lowest at 2.91%. Using non-menthol cigarettes with high and very high FV (≥23.4%) vs low FV (≤10.04%) was associated with a greater likeliness of misperceiving one’s cigarette variety to be less harmful than other varieties (p values<0.05). Total nicotine equivalent, biomarker for nicotine exposure, was elevated (p values<0.05) among three non-menthol groups (low, moderate and very high FV) compared with two menthol groups (moderate, very high FV).ConclusionThe well-documented harm misperception linked to higher FV is more apparent in those using non-menthol than menthol cigarettes. Increased exposures were observed among some non-menthol cigarette users compared with some menthol cigarette users. These results should by no means delay a menthol ban but rather motivate concerted public health efforts to accompany the menthol ban to maximise smoking cessation.

Funder

NIMHD of the NIH

National Cancer Institute

NIH

National Center for Advancing Translational Sciences of the National Institutes of Health

NCI of the NIH

Publisher

BMJ

Reference19 articles.

1. Tobacco Products Scientific Advisory Committee, U.S. Food and Drug Administration . Menthol cigarettes and public health: review of the scientific evidence and recommendations. 2011. Available: https://wayback.archive-it.org/7993/20170405201731/https:/www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterialsCommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommitteeTobaccoProductsScientificAdvisoryCommittee/UCM269697.pdf [Accessed 22 Apr 2024].

2. U.S. Department of Health and Human Services . The health consequences of smoking: 50 years of progress. A report of the surgeon general. Atlanta, GA U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

3. Pro-tobacco marketing and anti-tobacco campaigns aimed at vulnerable populations: a review of the literature;Cruz;Tob Induc Dis,2019

4. Menthol cigarette use among adults who smoke cigarettes, 2008-2020: rapid growth and widening inequities in the United States;Goodwin;Nicotine Tob Res,2023

5. Global review of tobacco product flavour policies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3